Effective induction of high-titer antibodies by viral vector vaccines

被引：125

作者：

Draper, Simon J. ^{[1
]}

Moore, Anne C. ^{[1
]}

Goodman, Anna L. ^{[1
]}

Long, Carole A. ^{[2
]}

Holder, Anthony A. ^{[3
]}

Gilbert, Sarah C. ^{[1
]}

Hill, Fergal ^{[4
]}

Hill, Adrian V. S. ^{[1
]}

机构：

[1] Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England

[2] NIAID, Lab Malaria & Vector Res, US NIH, Rockville, MD 20852 USA

[3] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England

[4] Imaxio, F-69007 Lyon, France

来源：

NATURE MEDICINE | 2008年 / 14卷 / 08期

基金：

英国医学研究理事会; 英国惠康基金;

关键词：

D O I：

10.1038/nm.1850

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Protein-in-adjuvant vaccines have shown limited success against difficult diseases such as blood-stage malaria. Here we show that a recombinant adenovirus-poxvirus prime-boost immunization regime (known to induce strong T cell immunogenicity) can also induce very strong antigen-specific antibody responses, and we identify a simple complement-based adjuvant to further enhance immunogenicity. Antibodies induced against a blood-stage malaria antigen by this viral vector platform are highly effective against Plasmodium yoelii parasites in mice and against Plasmodium falciparum in vitro.

引用

页码：819 / 821

页数：3

共 50 条

[31] Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies
Rakocevic, Goran
Raju, Raghavan
Semino-Mora, Cristina
Dalakas, Marinos C.
NEUROLOGY, 2006, 67 (06) : 1068 - 1070
[32] Single-step cloning-screening method: a new tool for developing and studying high-titer viral vector producer cells
A F Rodrigues
A S Formas-Oliveira
M R Guerreiro
H A Tomás
P M Alves
A S Coroadinha
Gene Therapy, 2015, 22 : 685 - 695
[33] Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
Shi, Qizhen
Wilcox, David A.
Fahs, Scot A.
Weiler, Hartmut
Wells, Clive W.
Cooley, Brian C.
Desai, Drashti
Morateck, Patricia A.
Gorski, Jack
Montgomery, Robert R.
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (07): : 1974 - 1982
[34] Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies
Rakocevic, G
Raju, R
Semino-Mora, C
Dalakas, MC
NEUROLOGY, 2006, 66 (05) : A152 - A152
[35] Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency
Nasimuzzaman, Md
Lynn, Danielle
Ernst, Rebecca
Beuerlein, Michele
Smith, Richard H.
Shrestha, Archana
Cross, Scott
Link, Kevin
Lutzko, Carolyn
Nordling, Diana
Russell, David W.
Larochelle, Andre
Malik, Punam
Van der Loo, Johannes C. M.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2016, 3 : 16004
[36] Single-step cloning-screening method: a new tool for developing and studying high-titer viral vector producer cells
Rodrigues, A. F.
Formas-Oliveira, A. S.
Guerreiro, M. R.
Tomas, H. A.
Alves, P. M.
Coroadinha, A. S.
GENE THERAPY, 2015, 22 (09) : 685 - 695
[37] PRODUCTION OF HIGH-TITER ENTEROVIRUS ANTISERA IN BABOONS
OCAMPO, AR
MELNICK, JL
AMERICAN JOURNAL OF HYGIENE, 1964, 79 (03): : 349 - &
[38] PROPAGATION AND PURIFICATION OF HIGH-TITER HUMAN CYTOMEGALOVIRUS
CHAMBERS, RW
ROSE, JA
RABSON, AS
BOND, HE
HALL, WT
APPLIED MICROBIOLOGY, 1971, 22 (05) : 914 - &
[39] High-titer blood-grouping serum
Terry, MC
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1935, 33 (01): : 14 - 15
[40] Viral vector vaccines
McCann, Naina
O'Connor, Daniel
Lambe, Teresa
Pollard, Andrew J.
CURRENT OPINION IN IMMUNOLOGY, 2022, 77

← 1 2 3 4 5 →